|
TUG1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.456200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.249000E-01 |
| Normal-vs-Stage2 |
5.019800E-01 |
| Normal-vs-Stage3 |
2.243600E-01 |
| Normal-vs-Stage4 |
1.343240E-01 |
| Stage1-vs-Stage2 |
2.874000E-01 |
| Stage1-vs-Stage3 |
6.599900E-02 |
| Stage1-vs-Stage4 |
4.972500E-02 |
| Stage2-vs-Stage3 |
8.437800E-01 |
| Stage2-vs-Stage4 |
6.689800E-01 |
| Stage3-vs-Stage4 |
7.319600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.956200E-01 |
| Normal-vs-AfricanAmerican |
7.599000E-01 |
| Normal-vs-Asian |
7.103600E-01 |
| Caucasian-vs-AfricanAmerican |
8.634200E-01 |
| Caucasian-vs-Asian |
6.183000E-01 |
| AfricanAmerican-vs-Asian |
6.560800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.419380E-01 |
| Normal-vs-Female |
3.241600E-01 |
| Male-vs-Female |
2.457000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.639200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.766400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.584000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.636630E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.025400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.168600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.086400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.061700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.492170E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.583000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.379200E-03 |
| Normal-vs-Grade 2 |
2.926000E-01 |
| Normal-vs-Grade 3 |
1.571220E-01 |
| Normal-vs-Grade 4 |
3.899400E-03 |
| Grade 1-vs-Grade 2 |
7.302400E-02 |
| Grade 1-vs-Grade 3 |
1.239780E-03 |
| Grade 1-vs-Grade 4 |
8.195100000008E-05 |
| Grade 2-vs-Grade 3 |
1.960450E-03 |
| Grade 2-vs-Grade 4 |
2.4829000000004E-05 |
| Grade 3-vs-Grade 4 |
5.632500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.302000E-02 |
| Normal-vs-ccB subtype |
7.596100E-02 |
| ccA subtype-vs-ccB subtype |
3.77220000000733E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.999800E-01 |
| Normal-vs-N1 |
4.209800E-02 |
| N0-vs-N1 |
1.034970E-01 |
|
|
